StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Antidilutive Securities Excluded from Diluted EPS by Year

Antidilutive Securities Excluded from Diluted EPS: RSUs & Performance Awards (thousand shares)

Natera Antidilutive Securities Excluded from Diluted EPS: 8,323.00 k_shares in FY2025, down 21.4% from a year earlier.

Latest, FY2025
8,323.00
Period ended Dec 31, 2025
Change on a year earlier
-21.4%
10,593.00 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (2026-02-27) ↗

Reported in Form 10-K/10-Q Note — Net Loss Per Share (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAntidilutive Securities Excluded from Diluted EPS: RSUs & Performance Awards (thousand shares)Year on yearSource
FY2025Dec 31, 20258,323.00-21.4%Form 10-K (2026-02-27) ↗
FY2024Dec 31, 202410,593.00+14.5%Form 10-K (2026-02-27) ↗
FY2023Dec 31, 20239,248.00+35.3%Form 10-K (2026-02-27) ↗
FY2022Dec 31, 20226,836.00+71.4%Form 10-K (2025-02-28) ↗
FY2021Dec 31, 20213,988.00–Form 10-K (2024-02-29) ↗

Breakdown

What makes up antidilutive Securities Excluded from Diluted EPS

Cite this data

StockData. (2026). Natera Antidilutive Securities Excluded from Diluted EPS, annual FY2021–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/antidilutive-rsu-perf-shares

See every metric in the Natera KPI table. Data updated Nov 2, 2026.